Pure Global

LIAISON® Control SARS-Cov-2 S1/S2 IgG - Indonesia BPOM Medical Device Registration

LIAISON® Control SARS-Cov-2 S1/S2 IgG is a medical device registered with Indonesia's BPOM (Badan Pengawas Obat dan Makanan) under Analysis ID AKL 20303220854. The device is manufactured by DIASORIN S.P.A from Italy, and is classified as Risk Class Kelas Resiko : B. The authorized representative in Indonesia is BIOMEDIKAL SCIENTIFIC INDONESIA.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, authorized representative details, product classification, and related products. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
BPOM Registered
Risk Class Kelas Resiko : B
LIAISON® Control SARS-Cov-2 S1/S2 IgG
Analysis ID: AKL 20303220854

Risk Classification

Kelas Resiko : B

Product Class

Kelas : 2

Manufacturer

DIASORIN S.P.A

Country of Origin

Italy

Authorized Representative

BIOMEDIKAL SCIENTIFIC INDONESIA

AR Address

18 Office Park 22nd F1 Suite E, F &G, Jalan TB SIMATUPANG 18

Registration Date

May 12, 2022

Expiry Date

Jan 12, 2023

Product Type

Serological Reagents

Respiratory viral panel multiplex nucleic acid assay

Invitro Diagnostics

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing